Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes
Diabetes, Obesity and Metabolism · 2024
DOI: 10.1111/dom.15760 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Ebaa Al-Ozairi und 5 weiteren Autor:innen. Beteiligte Einrichtung: DAFNE Unit, Clinical Care Research and Clinical Trials Unit, Dasman Diabetes Institute, Kuwait City, Kuwait. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Obesity, Liver Cirrhosis, Elasticity Imaging Techniques. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kuwait Foundation for the Advancement of Sciences (KFAS), Ministry of Health, Kuwait.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
To compare hepatic stiffness and fat fraction in patients with obesity and type 1 diabetes (T1D) with type 2 diabetes (T2D) with a similar body mass index (BMI).
Methods
In this prospective cross‐sectional study, 90 participants with T1D (BMI 30.5 ± 4.5 kg/m 2 ; diabetes duration 20.5 ± 9.8 years; HbA1c 8.2% ± 1.4%) and 69 with T2D (BMI: 30.8 ± 4.6 kg/m 2 ; diabetes duration: 11.7 ± 7.8 years; HbA1c: 7.3% ± 1.4%) were included. Liver fat fraction and stiffness were examined by magnetic resonance imaging and elastography, respectively. Logistic regressions were used to evaluate associations with biomedical variables.
Results
The mean liver stiffness score in patients with obesity and T1D was 2.2 ± 0.5 kPa, while in T2D it was 2.6 ± 0.8 kPa ( P < .001). The liver fat fraction in patients with obesity and T1D was 3.7% ± 6.3%, and in T2D it was 10.6% ± 7.9% ( P < .001). Metabolic dysfunction‐associated steatotic liver disease (MASLD) was present in 13.3% of patients with T1D and in 69.6% of patients with T2D, whereas fibrosis was suggested in 7.8% of patients with T1D and in 27.5% of patients with T2D. Liver stiffness was four times higher in patients with T2D compared with those with T1D (odds ratio = 5.4, 95% confidence interval: 2.1‐13.6, P < .001). Aspartate transaminase (AST), alanine transaminase, gamma‐glutamyl transferase (GGT), triglycerides and the android‐to‐gynoid ratio were associated with elevated fat fraction in both cohorts. AST and GGT were associated with elevated liver stiffness in both cohorts.
Conclusions
Patients with obesity and T1D had lower liver fat and liver stiffness compared with those patients with T2D, despite similar levels of BMI, a longer duration of diabetes and worse glycaemic control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- DAFNE Unit, Clinical Care Research and Clinical Trials Unit, Dasman Diabetes Institute, Kuwait City, Kuwait.
- Amiri Hospital, Ministry of Health, Kuwait City, Kuwait.
- Diagnostic Imaging Centre, Dasman Diabetes Institute, Kuwait City, Kuwait.
- Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.
- Diabetes Research Centre, Ulster University, Belfast, UK.
ORCID-Profile: Ebaa Al-Ozairi, Mohammad Irshad, Carel W le Roux
Förderung
- Kuwait Foundation for the Advancement of Sciences (KFAS)
- Ministry of Health, Kuwait
Zitieren
APA
Al-Ozairi, E., Irshad, M., AlKandari, J., Mashankar, A., Alroudhan, D., & le Roux, C. W. (2024). Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15760
Vancouver
Al-Ozairi E, Irshad M, AlKandari J, Mashankar A, Alroudhan D, le Roux CW. Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15760
BibTeX
@article{AlOzairi2024,
author = {Al-Ozairi, Ebaa and Irshad, Mohammad and AlKandari, Jumana and Mashankar, Anant and Alroudhan, Dherar and le Roux, Carel W},
title = {Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
doi = {10.1111/dom.15760}
}
EUVIMED